Sep 25, 2026 by Daniel SparksCoca-Cola Hasn't Sold Much More Soda in a Decade. Its Dividend Has Gone Up Every Year Anyway.The beverage giant sells only about 16% more product than it did ten years ago, yet its payout is up 61%. What keeps funding the raises?
Sep 25, 2026 by Jeremy BowmanIf I Could Only Add 1 ETF to My Portfolio This Year, Here's Exactly What I'd BuyThis semiconductor ETF continues to look ripe for more gains.
Sep 25, 2026 by Daniel SparksShould You Buy Microsoft Stock Now That It's Back Within 6% of Its Record?After a 46% rise from its June low, is the software giant still a buy?
Sep 25, 2026 by John BallardCoupang vs. Shopify: Which Stock Is a Better Buy in 2026?Coupang offers better value, but Shopify is seeing accelerating growth from AI-driven traffic.
Sep 25, 2026 by Reuben Gregg BrewerThe Case for Selling SpaceX Stock Before its December Lock-Up ExpirationSpaceX could be dead money until insiders have had the opportunity to sell shares.
Sep 25, 2026 by Joe TenebrusoWhy Microsoft Stock Is Up TodayThe software giant is rolling out more enterprise AI offerings.
Sep 25, 2026 by Robert IzquierdoC3.ai CEO Thomas Siebel Sells Over 444,000 Shares Worth $4.8 Million After a 40% Decline in the StockThe artificial intelligence software provider reported a notable executive sale amid a big drop in the share price over the past year.
Sep 25, 2026 by Daniel SparksCoca-Cola Hasn't Sold Much More Soda in a Decade. Its Dividend Has Gone Up Every Year Anyway.The beverage giant sells only about 16% more product than it did ten years ago, yet its payout is up 61%. What keeps funding the raises?
Sep 25, 2026 by Jeremy BowmanIf I Could Only Add 1 ETF to My Portfolio This Year, Here's Exactly What I'd BuyThis semiconductor ETF continues to look ripe for more gains.
Sep 25, 2026 by Daniel SparksShould You Buy Microsoft Stock Now That It's Back Within 6% of Its Record?After a 46% rise from its June low, is the software giant still a buy?
Sep 25, 2026 by Parkev Tatevosian, CFADo Food Delivery Robots Make DoorDash Stock a No-Brainer Buy?Lowering the cost to serve customers makes it easier for DoorDash to grow the business.
Sep 25, 2026 by Parkev Tatevosian, CFAGreat News for IonQ Stock Investors!Innovations like these make it easier for IonQ to raise capital.
Sep 25, 2026 by Parkev Tatevosian, CFAWalmart Has Arguably Been the Best E-Commerce Business in Recent YearsWalmart has earned its premium valuation.
Sep 25, 2026 by Parkev Tatevosian, CFAShould Investors Buy Visa Instead of Mastercard?You might be surprised at the conclusion.
Sep 25, 2026 by Parkev Tatevosian, CFAIs it Safe to Buy Salesforce Stock Right Now?In a surprise shift, revenue growth is accelerating.
Sep 25, 2026 by Parkev Tatevosian, CFAIs ServiceNow the Ultimate Enterprise Software Stock?Management has done an excellent job assuaging investor concerns over AI.
Sep 25, 2026 by Reuben Gregg Brewer2 Green Flags and 2 Red Flags for Nuclear Stocks After This Year's Sell-OffNuclear power has a huge opportunity ahead of it as a reliable baseload power source, but that doesn't mean every nuclear power stock will be a winner.
Sep 25, 2026 by Eric VolkmanWhy Atlas Energy Solutions Surged Almost 14% Higher on FridayThe company announced not one but two cost-reimbursement contracts with a major client.
Sep 25, 2026 by Robert IzquierdoQuinStreet's 2026 Outlook: AI-Driven Marketing Platform Sees Strong Revenue GrowthThis under-the-radar marketing platform stock boasts a Superscore of 73 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Sep 25, 2026 by Daniel SparksNvidia Would Have to Add Almost a Whole Broadcom to Reach $7 TrillionClosing a $1.55 trillion gap might take less time than its size suggests.
Sep 25, 2026 by Eric VolkmanWhy Staar Surgical Stock Soared TodayIt has launched a $50 million share repurchase program.
Sep 25, 2026 by Jeremy BowmanIs Super Micro Computer a Buy?The AI server-maker is growing quickly, but will it last?
Sep 25, 2026 by Brendan CoffeyAbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?AbbVie bets on pipeline diversification amid patent cliffs, while J&J's higher profitability masks litigation risks, a choice between growth ambition and defensive stability.